You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
迪安诊断(300244.SZ)预计2020年净利7.12亿元-8.16亿元 同比增长105%-135%
格隆汇 01-27 17:46

格隆汇1月27日丨迪安诊断(300244.SZ)披露2020年度业绩预告,公司预计2020年度实现归属于上市公司股东的净利润7.12亿元-8.16亿元,同比增长105%-135%。业绩增长原因系:

1、报告期内,新冠肺炎疫情爆发,公司依托已有的业务布局,全国一盘棋,高效助力各省市抗疫防疫攻坚,新冠检测业务增量明显;随着国内疫情防控成果不断巩固,医院门诊量逐步恢复,公司坚守“以客户为中心,以临床为导向”,加大研发投入,推动学科和技术的驱动,传统检验业务和产品代理业务也弹性回升。同时,公司持续加强精益管理,优化运营效率,经营性现金流量净额约15亿元,较上年同期大幅增长,营业收入和净利润亦呈现健康强劲增长态势。

2、公司主要商誉形成是为了顺应以公立为主的医疗体制特质及医保控费下价值医疗的发展趋势,强化行业内独有的“服务+产品”一体化商业模式的竞争优势,从而收购优质渠道商所构成。公司现已完成了渠道和检验在团队、文化、管理、业务及供应链等各维度的协同和融合,真正整体化解决方案的差异化竞争优势逐渐凸显,但2020年受新冠疫情的一定影响,根据相关收购子公司的年度经营情况,出于谨慎性原则,公司对商誉资产进行了初步减值测试,预计计提商誉减值准备约4.2亿-4.5亿元。最终金额待审计、评估机构进行审评后方可确定。

3、预计2020年度非经常性损益对归属于上市公司股东净利润的影响金额约为5000万元-6200万元,基本为对外投资股权处置收益及收到的政府补助。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account